Dr. Edward Stanley Emery Iii

MD | Neurology


  111 Colchester Ave, Patrick 5, Burlington
     Vermont, 05401-1473
  802-847-2788    Maps & Directions
Dr. Edward Stanley Emery Iii is a Burlington, Vermont based neurologist who is specialized in Neurology. His current practice location is 111 Colchester Ave, Patrick 5, Burlington. Patients can reach him at 802-847-2788. Dr. Edward Stanley Emery Iii is MD in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1609899962.
Dr. Edward Stanley Emery Iii specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Edward Stanley Emery Iii speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Edward Stanley Emery Iii
Specialization: Neurology
Gender:Male
Credentials: MD
Practice Address:111 Colchester Ave, Patrick 5, Burlington,
Vermont, 05401-1473
Phone:802-847-2788
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1609899962
NPI Enumeration Date: 26 Jul, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Edward Stanley Emery Iii
1549 Hinesburg Rd,
South Burlington, Vermont
Zip: 05403-7622
Phone Number: 802-862-6246
Patients can reach Dr. Edward Stanley Emery Iii at 111 Colchester Ave, Patrick 5, Burlington, Vermont or can call to book an appointment on 802-847-2788.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.